Members |
targetComponentId |
biverkning av natriumklodronat |
Adverse reaction to clodronic acid |
natriumklodronatallergi |
Allergy to clodronic acid (finding) |
natriumkromoglikat 2 %, ögondroppar |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
natriumkromoglykat 2 %, ögondroppar utan konserveringsmedel |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
natriumkromoglikat 20 mg, inhalationskapsel |
Sodium cromoglicate 20 mg/actuation powder for inhalation |
natriumkromoglikat 20 mg/2 ml, för nebulisator |
Sodium cromoglicate 10 mg/mL solution for inhalation |
natriumkromoglikat 5 mg, inhalator + spacer |
Sodium cromoglicate 5 mg/actuation powder for inhalation |
biverkning av natriumkromoglikat |
Adverse reaction to cromoglicic acid |
natriumkromoglikatallergi |
Allergy to cromoglicic acid (finding) |
Sodium diatrizoate 25% infusion |
Amidotrizoic acid-containing product in parenteral dose form |
natriumdiatrizoat 25 % infusionsvätska, lösning, flaska |
Amidotrizoic acid-containing product in parenteral dose form |
Sodium diatrizoate 25% injection |
Amidotrizoic acid-containing product in parenteral dose form |
natriumdiatrizoat 25 % injektionsvätska, lösning, ampull |
Amidotrizoic acid-containing product in parenteral dose form |
Sodium diatrizoate 45% injection |
Amidotrizoic acid-containing product in parenteral dose form |
natriumdiatrizoat 45 % injektionsvätska, lösning, ampull |
Amidotrizoic acid-containing product in parenteral dose form |
Sodium diatrizoate powder BP |
Product containing amidotrizoic acid (medicinal product) |
natrium-järn(III)glukonatkomplex 12,5 mg/ml, injektionsvätska, lösning, ampull |
Product containing precisely ferric ion (as sodium ferric gluconate complex) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
natriumfluorid 0,2 % |
Product containing only sodium fluoride (medicinal product) |
Sodium fluoride 1.1% |
Product containing only sodium fluoride (medicinal product) |
natriumfluorid 1,1 %, kräm |
Fluoride ion (as sodium fluoride) 11 mg/g dental paste |
natriumfluorid 1,1 %, gel |
Fluoride ion (as sodium fluoride) 11 mg/g dental paste |
natriumfluorid 1,1 %, pasta |
Fluoride ion (as sodium fluoride) 11 mg/g dental paste |
natriumfluorid 1,1 mg/ml |
Product containing only sodium fluoride (medicinal product) |
natriumfluorid 1,23 %, pasta |
Fluoride ion (as sodium fluoride) 12.3 mg/g dental paste |
natriumfluorid 2 % |
Product containing only sodium fluoride (medicinal product) |
natriumfluorid 2 %, munhålelösning |
Product containing only sodium fluoride in oromucosal dose form (medicinal product form) |
natriumfluorid 2 %, sköljvätska |
Product containing only sodium fluoride in oromucosal dose form (medicinal product form) |
natriumfluorid 2 %, lösning |
Product containing only sodium fluoride (medicinal product) |
natriumfluorid 2,21 mg, sugtablett |
Product containing precisely fluoride ion (as sodium fluoride) 2.21 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
natriumfluorid 2,2 mg, sugtablett |
Product containing precisely fluoride ion (as sodium fluoride) 2.21 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
natriumfluorid 2,50 mg/ml, lösning |
Product containing only sodium fluoride (medicinal product) |
natriumfluorid 2,72 %, pasta |
Fluoride ion (as sodium fluoride) 27.2 mg/g dental paste |
natriumfluorid 2,73 %, pasta |
Product containing only sodium fluoride (medicinal product) |
natriumfluorid 2,9 %, pasta |
Product containing precisely fluoride ion (as sodium fluoride) 29 milligram/1 gram conventional release toothpaste (clinical drug) |
natriumfluoridallergi |
Allergy to fluoride |
biverkning av natriumfusidat |
Fusidic acid adverse reaction |
överdos av natriumfusidat |
Fusidic acid overdose |
överdos av natriumfusidat, med oklar avsikt |
Fusidic acid overdose |
natriumhyaluronat 10 mg/ml, injektionsvätska, lösning, förfylld spruta 0,85 ml |
Sodium hyaluronate 10 mg/mL solution for injection |
natriumhyaluronat 10 mg/ml, injektionsvätska för intraokulärt bruk, förfylld spruta 0,55 ml |
Sodium hyaluronate 10 mg/mL solution for injection |
natriumhypoklorit 10 mikrogram/ml, ögondroppar |
Product containing only hyaluronic acid in ocular dose form (medicinal product form) |
natriumhyaluronat 10 mikrogram/ml, ögondroppar utan konserveringsmedel |
Product containing only hyaluronic acid in ocular dose form (medicinal product form) |
natriumhyaluronat 15 mg/ml, injektionsvätska, lösning, förfylld spruta |
Hyaluronic acid only product in parenteral dose form |
natriumhyaluronat 23 mg/ml, injektionsvätska, lösning, förfylld spruta |
Product containing precisely sodium hyaluronate 23 milligram/1 milliliter conventional release solution for injection (clinical drug) |
biverkning av natriumhyaluronat |
Adverse reaction to hyaluronic acid (disorder) |
natriumhyaluronatallergi |
Allergy to hyaluronic acid |
natriumhypoklorit 0,5 %, lösning |
Sodium hypochlorite only product |
natriumhypoklorit 8 %, kutan lösning |
Product containing only sodium hypochlorite in cutaneous dose form (medicinal product form) |
stark natriumkloritlösning 8 % |
Product containing only sodium hypochlorite in cutaneous dose form (medicinal product form) |
natriumjododid (^131^I) 333 kBq-3,7 MBq, diagnostisk kapsel |
Sodium iodide (131-I) only product in oral dose form |
Sodium iodide[131I] 37-7400MBq injection |
Sodium iodide (131-I) only product in parenteral dose form |
natriumjodid (^131^I) 37-7 400 MBq, pulver för beredning av injektionsvätska, lösning, flaska |
Sodium iodide (131-I) only product in parenteral dose form |
natriumjododid (^131^I) 37-7 400 MBq, behandlingskapsel |
Sodium iodide (131-I) only product in oral dose form |
natriumjododid (^131^I) 37-5 550 MBq, behandlingskapsel |
Sodium iodide (131-I) only product in oral dose form |
natriumjodid (^131^I) 740 MBq/ml, injektionsvätska |
Sodium iodide (131-I) only product in parenteral dose form |
natriumjodhippurat (^123^I), injektionsvätska |
Product containing only iodohippurate (123-I) sodium in parenteral dose form (medicinal product form) |
natriumjodhippurat (^131^I) 18,5 MBq/ml, injektionsvätska |
Product containing only iodohippurate (123-I) sodium in parenteral dose form (medicinal product form) |
natriumjodhippurat (^131^I) 20 MBq/ml, injektionsvätska |
Product containing only iodohippurate (123-I) sodium in parenteral dose form (medicinal product form) |
natriumjotalamat 54 %, injektionsvätska, lösning |
Iothalamic acid only product |
natriumlaktat 0,16 mol per liter, infusionsvätska, lösning, påse |
Sodium lactate only product in parenteral dose form |
natriumnitroprussid 25 mg/ml, injektionsvätska, lösning, ampull |
Product containing precisely sodium nitroprusside 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
biverkning av natriumnitroprussid |
Adverse reaction to nitroprusside |
natriumnitroprussidallergi |
Allergy to nitroprusside (finding) |
natriumperborat 68,6 %, munhålelösning |
Sodium perborate 686 mg/mL oromucosal solution for mouthwash |
natriumperborat 68,6 %, munsköljvätska |
Sodium perborate 686 mg/mL oromucosal solution for mouthwash |
natriumpikosulfat 10 mg per dospåse, oralt pulver |
Product containing precisely sodium picosulfate 66.7 microgram/1 milliliter conventional release oral solution (clinical drug) |
natriumpolystyrensulfonat 100 %, pulver |
Polystyrene sulfonate only product |
natriumpolystyrensulfonat 4,1 milliekvivalenter/g, pulver |
Polystyrene sulfonate only product |
natriumpolystyrensulfonat 454 g pulver/flaska för suspenstion |
Polystyrene sulfonate only product |
natriumstiboglukonat 100 mg/ml, injektionsvätska, lösning, flaska 100 ml |
Product containing precisely sodium stibogluconate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
natriumtiosalicylat 50 mg/ml, injektionsvätska, lösning, ampull |
Product containing precisely sodium thiosalicylate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
natriumtiosulfatallergi |
Non-allergic hypersensitivity to sodium thiosulfate (finding) |
natriumvalproat 100 mg, tablett |
Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug) |
natriumvalproat 100 mg, krossbar tablett |
Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug) |
fynd som rör TNM-stadieindelning tumör i mjukdelar |
American Joint Committee on Cancer allowable value |
mjukvävnadsknöl i buken |
Soft tissue mass |
mjukvävnadsknöl i huvudet |
Soft tissue mass |
mjukvävnadsknöl i nedre extremitet |
Soft tissue mass |
mjukvävnadsknöl i halsen |
Soft tissue mass |
mjukvävnadsknöl i pelvis |
Soft tissue mass |
mjukvävnadsknöl i torax |
Soft tissue mass |
mjukvävnadsknöl i övre extremitet |
Soft tissue mass |
Soft tissue repair |
Repair - action |
Soft tissues of trunk |
Structure of soft tissues of trunk |
Solid prosthetic ligament reconstruction |
Repair - action |
solitär fibrös tumör, malign |
Solitary fibrous tumor and hemangiopericytoma grade 3 (morphologic abnormality) |
plasmocytom |
Plasmacytoma |
abdominal somatisk dysfunktion |
Somatic dysfunction of abdominal region (finding) |
somatisk dysfunktion i knä |
Somatic dysfunction of knee region (finding) |
somatisk orsak till impotens |
Erectile dysfunction due to psychophysiologic disorder (disorder) |
Somatotropin inhibiting factor preparation |
Product containing somatostatin (medicinal product) |
Somatropin 1.5mg powder |
Somatropin only product in parenteral dose form |
somatropin 1,5 mg, pulver till injektionsvätska, lösning, flaska |
Somatropin only product in parenteral dose form |
somatropin 1,5 mg, pulver till injektionsvätska, flaska + spädningsvätska |
Somatropin only product in parenteral dose form |
somatropin 10 mg/flaska, lösning |
Somatropin 10 mg/mL solution for injection |
Somatropin 5.8mg powder |
Somatropin only product in parenteral dose form |
somatropin (rbe) 5,8 mg, pulver till injektionsvätska, lösning, flaska |
Somatropin only product in parenteral dose form |
somatropin 5,8 mg, pulver till injektionsvätska, flaska + spädningsvätska |
Somatropin only product in parenteral dose form |
somatropin och somatropinagonist |
Growth hormone receptor agonist |
somatropin (epr) 10 mg/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Somatropin only product in parenteral dose form |
somatropin (epr) 3,33 mg/ml, injektionsvätska, lösning, cylinderampull 1,5 ml |
Somatropin only product in parenteral dose form |